Logos Global Management »

Editas Medicine shares owned by Logos Global Management

Quarter-by-quarter ownership of Editas Medicine (EDIT) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Editas Medicine

Tip: Access up to 7 years of quarterly data

All positions including Editas Medicine held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Editas Medicine by Logos Global Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.2M 2.2M 3.24

More positions owned by Logos Global Management

Erasca (ERAS)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Ideaya Biosciences (IDYA)
Biontech Se Sponsored Ads (BNTX)
Vera Therapeutics Cl A (VERA)
Tango Therapeutics (TNGX)
Praxis Precision Medicines I Com New (PRAX)
Celldex Therapeutics Com New (CLDX)
Dianthus Therapeutics (DNTH)
Cg Oncology (CGON)
Disc Medicine (IRON)
Maze Therapeatics (MAZE)
Dyne Therapeutics (DYN)
Moonlake Immunotherapeutics Class A Ord (MLTX)

View all positions for Logos Global Management

Top funds holding Editas Medicine

TCG Crossover Management
BlackRock
ADAR1 Capital Management
RA Capital Management
Commodore Capital
Vanguard Capital Management
Paradigm Biocapital Advisors
Opaleye Management
Vanguard Portfolio Management
Woodline Partners
Vivo Capital
Goldman Sachs Group
Geode Capital Management
Renaissance Technologies
Logos Global Management

View all funds holding Editas Medicine